Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study

Background: Neuroendocrine carcinoma of the cervix (NECC) is a rare malignancy, and pretreatment overall survival (OS) assessment remains limited. We developed and externally validated an MRI radiomics model for OS risk stratification. Methods: This retrospective study included 128 patients: Center 1 served as the development cohort (n = 90), and Center 2 as the independent external validation cohort (n = 38). The model was selected using development data and locked before validation. Evaluation included Harrell C-index, inverse-probability-of-censoring-weighted (IPCW) AUC, calibration, Brier score, decision-curve analysis, and survival stratification. Results: The model comprised three intratumoral T2-weighted imaging features fitted using CoxBoost 1.5.2. Its external C-index was 0.737 (95% CI, 0.615–0.850), compared with 0.633 (95% CI, 0.523–0.749) for the revised clinical model; the paired difference was 0.104 (95% CI, −0.018 to 0.226). A nested sensitivity analysis of the automated selection procedure yielded a mean C-index of 0.592 (SD, 0.049). IPCW AUCs were 0.741 (95% CI, 0.562–0.891) at 3 years and 0.763 (95% CI, 0.583–0.919) at 5 years. At 3 and 5 years, calibration intercepts were 0.03 and −0.09, slopes 1.14 and 1.20, and Brier scores 0.202 and 0.195, respectively. Exploratory decision-curve analysis suggested potential net benefit over selected thresholds. Hazard ratios (HRs; 95% CIs) for high versus low risk were 1.96 (1.06–3.62) and 3.61 (1.39–9.38) in the development and external cohorts, respectively. Corresponding HRs per development-cohort SD increase in the score were 1.83 (1.29–2.60) and 2.42 (1.45–4.04). Conclusions: The pretreatment MRI radiomics model showed external prognostic discrimination for OS in NECC, but superiority over the pretreatment clinical model was not demonstrated. Further independent validation is needed.

Authors

Institutions

Publication Details

Journal
Tomography
Published
2026-11-17
DOI
https://doi.org/10.3390/tomography12110165
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study

Haijuan Yu, Jian Chen, Yang Sun, Rong Lin et al.
2 links
Tomography
Radiomics and Machine Learning in Medical Imaging
article

Pretreatment MRI Radiomics for Overall Survival Risk Stratification in Neuroendocrine Carcinoma of the Cervix: A Development and External Validation Study

Haijuan Yu, Jian Chen, Yang Sun, Rong Lin, Fengle Jiang, Ning Ma, Xingfa Chen
article en

Abstract

Background: Neuroendocrine carcinoma of the cervix (NECC) is a rare malignancy, and pretreatment overall survival (OS) assessment remains limited. We developed and externally validated an MRI radiomics model for OS risk stratification. Methods: This retrospective study included 128 patients: Center 1 served as the development cohort (n = 90), and Center 2 as the independent external validation cohort (n = 38). The model was selected using development data and locked before validation. Evaluation included Harrell C-index, inverse-probability-of-censoring-weighted (IPCW) AUC, calibration, Brier score, decision-curve analysis, and survival stratification. Results: The model comprised three intratumoral T2-weighted imaging features fitted using CoxBoost 1.5.2. Its external C-index was 0.737 (95% CI, 0.615–0.850), compared with 0.633 (95% CI, 0.523–0.749) for the revised clinical model; the paired difference was 0.104 (95% CI, −0.018 to 0.226). A nested sensitivity analysis of the automated selection procedure yielded a mean C-index of 0.592 (SD, 0.049). IPCW AUCs were 0.741 (95% CI, 0.562–0.891) at 3 years and 0.763 (95% CI, 0.583–0.919) at 5 years. At 3 and 5 years, calibration intercepts were 0.03 and −0.09, slopes 1.14 and 1.20, and Brier scores 0.202 and 0.195, respectively. Exploratory decision-curve analysis suggested potential net benefit over selected thresholds. Hazard ratios (HRs; 95% CIs) for high versus low risk were 1.96 (1.06–3.62) and 3.61 (1.39–9.38) in the development and external cohorts, respectively. Corresponding HRs per development-cohort SD increase in the score were 1.83 (1.29–2.60) and 2.42 (1.45–4.04). Conclusions: The pretreatment MRI radiomics model showed external prognostic discrimination for OS in NECC, but superiority over the pretreatment clinical model was not demonstrated. Further independent validation is needed.

TomographyVol. 12(11)
Fujian Medical University (CN), Fujian Provincial Hospital (CN), Fujian Provincial Cancer Hospital (CN)
Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project
Good health and well-being
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon